United States · 
Who invested in COTA (Cancer Outcomes Tracking and Analysis)?
COTA (Cancer Outcomes Tracking and Analysis)'s investors include Horizon Healthcare Services, Med-Metrix and Horizon Blue Cross Blue Shield of New Jersey.
United States · Series A startup
Who invested in COTA (Cancer Outcomes Tracking and Analysis)
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$3.7Mraised across 1 round since 2014, from 1 source
- Latest round
- Series A, $3.7MSept 2014
- Investors
- 3
The rounds
- Sept 2014Series A$3.7M
From a historical funding record
Everyone who backed them
Horizon Healthcare ServicesVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about COTA (Cancer Outcomes Tracking and Analysis)
How much has COTA (Cancer Outcomes Tracking and Analysis) raised?
COTA (Cancer Outcomes Tracking and Analysis) has raised $3.7M across 1 round since 2014.
When did COTA (Cancer Outcomes Tracking and Analysis) last raise?
COTA (Cancer Outcomes Tracking and Analysis)'s most recent round was a Series A of $3.7M in Sept 2014.
What was COTA (Cancer Outcomes Tracking and Analysis)'s biggest round?
Its most recent round, $3.7M in Sept 2014, is also its largest on record.
Who backed COTA (Cancer Outcomes Tracking and Analysis) first?
COTA (Cancer Outcomes Tracking and Analysis)'s first round on record, in Sept 2014, was backed by Horizon Healthcare Services, Med-Metrix and Horizon Blue Cross Blue Shield of New Jersey.
What stage is COTA (Cancer Outcomes Tracking and Analysis) at?
COTA (Cancer Outcomes Tracking and Analysis)'s latest named round is a Series A, in Sept 2014.
Where is COTA (Cancer Outcomes Tracking and Analysis) based?
COTA (Cancer Outcomes Tracking and Analysis) is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.